Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:888 (18 October), doi:10.1136/bmj.327.7420.888
London Susan Mayor
The benefits of hormone replacement therapy (HRT) may outweigh the risks if the woman has distressing menopausal symptoms or a premature menopause -- but no evidence exists to support a role for HRT in osteoporosis, heart disease, or Alzheimer's disease. This is the message of a consensus statement issued by a conference held in the United Kingdom this week.
The conference was convened by the Royal College of Physicians of Edinburgh to clarify the use of HRT in clinical practice in response to growing concern about its safety. Results from several major trials published recently, including the million women study (16 August, p 359), have shown that certain types of HRT could double the risk of breast cancer over 10 years in some women.
David Purdie, director of the Edinburgh Osteoporosis Centre, Edinburgh, and chairman of the conference organising committee, said: "We believe that the guidance will
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses